MM Capital’s Favorite Healthcare Stocks in Q3

Following is information regarding MM Capital LLC’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011:

  • Procter & Gamble, Inc. (NYSE:PG): On 6/30/11 MM Capital LLC reported holding 57,702 shares with a market value of $3,668,116. This comprised 0.88% of the total portfolio. On 9/30/11, MM Capital LLC held 281,602 shares with a market value of $17,791,614. This comprised 2.23% of the total portfolio. The net change in shares for this position over the two quarters is 223,900. About the company: The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Proctor & Gamble’s products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
  • CVS Caremark Corporation (NYSE:CVS): On 6/30/11 MM Capital LLC reported holding 36,924 shares with a market value of $1,387,604. This comprised 0.33% of the total portfolio. On 9/30/11, MM Capital LLC held 351,823 shares with a market value of $11,817,735. This comprised 1.48% of the total portfolio. The net change in shares for this position over the two quarters is 314,899. About the company: CVS Caremark Corporation is an integrated pharmacy health care provider. The Company’s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.
  • MedcoHealth Solutions, Inc. (NYSE:MHS): On 6/30/11 MM Capital LLC reported holding 74,051 shares with a market value of $4,185,363. This comprised 1.00% of the total portfolio. On 9/30/11, MM Capital LLC held 186,533 shares with a market value of $8,746,532. This comprised 1.10% of the total portfolio. The net change in shares for this position over the two quarters is 112,482. About the company: Medco Health Solutions, Inc. is a pharmacy benefit manager. The Company provides programs and services for its clients and the members of their pharmacy benefit plans, and for the physicians and pharmacies the members use.
  • Medtronic, Inc. (NYSE:MDT): On 6/30/11 MM Capital LLC reported holding 5,196 shares with a market value of $200,202. This comprised 0.05% of the total portfolio. On 9/30/11, MM Capital LLC held 262,505 shares with a market value of $8,725,667. This comprised 1.09% of the total portfolio. The net change in shares for this position over the two quarters is 257,309. About the company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Celgene Corporation (NASDAQ:CELG): On 6/30/11 MM Capital LLC reported holding 66,261 shares with a market value of $3,996,863. This comprised 0.96% of the total portfolio. On 9/30/11, MM Capital LLC held 117,362 shares with a market value of $7,265,881. This comprised 0.91% of the total portfolio. The net change in shares for this position over the two quarters is 51,101. About the company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • McKesson Corporation (NYSE:MCK): On 6/30/11 MM Capital LLC reported holding 15,091 shares with a market value of $1,262,362. This comprised 0.30% of the total portfolio. On 9/30/11, MM Capital LLC held 85,997 shares with a market value of $6,251,982. This comprised 0.78% of the total portfolio. The net change in shares for this position over the two quarters is 70,906. About the company: McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise. In addition, McKesson offers analytic, care management, and patient solutions for payers.
  • Cardinal Health, Inc. (NYSE:CAH): On 6/30/11 MM Capital LLC reported holding 4,862 shares with a market value of $220,832. This comprised 0.05% of the total portfolio. On 9/30/11, MM Capital LLC held 104,476 shares with a market value of $4,375,455. This comprised 0.55% of the total portfolio. The net change in shares for this position over the two quarters is 99,614. About the company: Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers. The Company’s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising.
  • Gilead Sciences, Inc. (NASDAQ:GILD): On 6/30/11 MM Capital LLC reported holding 31,846 shares with a market value of $1,318,743. This comprised 0.32% of the total portfolio. On 9/30/11, MM Capital LLC held 95,791 shares with a market value of $3,716,691. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is 63,945. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Merck & Co., Inc. (NYSE:MRK): On 6/30/11 MM Capital LLC reported holding 13,802 shares with a market value of $487,073. This comprised 0.12% of the total portfolio. On 9/30/11, MM Capital LLC held 112,043 shares with a market value of $3,663,806. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is 98,241. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Pfizer, Inc. (NYSE:PFE): On 6/30/11 MM Capital LLC reported holding 47,749 shares with a market value of $983,629. This comprised 0.24% of the total portfolio. On 9/30/11, MM Capital LLC held 180,390 shares with a market value of $3,189,295. This comprised 0.40% of the total portfolio. The net change in shares for this position over the two quarters is 132,641. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

(Note: Data regarding MM Capital LLC’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Check out our analysis of Jim Cramer’s latest stock calls

More from The Cheat Sheet